Detailed Information
Cited 43 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Amivantamab in combination with lazertinib for the treatment of osimertinib-relapsed, chemotherapy-naive EGFR mutant (EGFRm) non-small cell lung cancer (NSCLC) and potential biomarkers for response.
- Authors
- Bauml, Joshua; Cho, Byoung Chul; Park, Keunchil; Lee, Ki Hyeong; Cho, Eun Kyung; Kim, Dong-Wan; Kim, Sang-We; Haura, Eric B.; Sabari, Joshua K.; Sanborn, Rachel E.; Nagasaka, Misako; Ou, Sai-Hong Ignatius; Minchom, Anna Rachel; Gomez, Jorge E.; Curtin, Joshua C.; Gao, Grace; Roshak, Amy; Thayu, Meena; Knoblauch, Roland Elmar; Spira, Alexander I.
- Issue Date
- May-2021
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 39
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Cho, Eun Kyung
- College of Medicine (Department of Medicine)